LAUSR

Biology 2 Breast 11 CNS 8 GI 5 GU 10 GYN 0 H&N 2 Hematologic 2 Pediatric 2 Sarcoma 1 Thoracic 10 Other 28 The year 2018 has been a successful one for ASTRO’s Advances in Radiation Oncology. As we enter our third year of publishing, submissions are continuing to increase across a wide range of interdisciplinary topics. Advances is currently on target to receive over 200 submissions this year, a roughly 50% increase over 2017. Because of the hard work of the American Society for Radiation Oncology (ASTRO) membership in serving as peer reviewers, our time to first decision has declined to only 38 days. Advances was indexed in PubMed Central in 2017. Although we have yet to receive an impact factor, our Citescore stood at 0.70 in July 2018. Over the last year, the single biggest area of growth in manuscript submissions to Advances has been in manuscripts involving multiple disease sites or multidisciplinary studies, such as immunotherapy and radiation oncology (Table 1). Our new cover reflects the multidisciplinary nature of the science published in Advances. A special edition on immunotherapy and radiation